Funded by grants from the European Community (CI 1-0371-F(CD)); the Fondo
de Investigaciones Sanitarias (FIS), Spain (86/753, 87/1513, 88/2049,
90/0901, 95/0955, 01/1237, 01/1236, and BAE 01/5013); the International
Agency for Research on Cancer, Lyons, France (FI/92/3-2 PAR);
Preventiefonds, the Netherlands (28-1502€1); Programa Interministerial de
Investigación y Desarrollo, Spain (SAF 96/0323); the Conselho Nacional de
Desenvolvimiento Cientifico e Tecnologico, Brazil (JEN-204453/88€7); the
Department of Reproductive Health and Research of the World Health
Organization (98€101); and a Union International contre le Cancer
Yamagiwa-Yoshida Memorial International Cancer Study Grant.
We are indebted to the women and men who participated in the study; to the
gynecologists, pathologists, oncologists, and supervisors involved in the
fieldwork that made the original studies possible; and to A. Arslan and M.
Diaz for their technical assistance in data management.
Source Information
From the Servei d'Epidemiologia i Registre del Càncer, Institut Català
d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain (X.C., F.X.B.,
S.S.); the International Agency for Research on Cancer, Lyons, France
(N.M., J.S.S., R.H., S.F.); Free University Hospital, Amsterdam
(C.J.L.M.M.); Johns Hopkins University, Baltimore (K.V.S.); Universidade
de São Paulo, São Paulo, Brazil (J.E.-N.); Philippine General Hospital,
University of the Philippines, Manila, the Philippines (C.A.N.); the
Faculty of Medicine, Prince of Songkla University, Hat-Yai, Thailand
(S.C.); and Proyecto Epidemiológico Guanacaste, San José, Costa Rica
(R.H.).
Victor Moreno, M.D., Servei d'Epidemiologia i Registre del Càncer,
Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain,
was also an author.
Address reprint requests to Dr. Castellsagué at the Servei d'Epidemiologia
i Registre del Càncer, Institut Català d'Oncologia, Gran Via s/n, Km 2.7,
08907 Hospitalet de Llobregat, Barcelona, Spain, or at
xcastellsague@ico.scs.es.
References
1. Hutchinson J. On the influence of circumcision in preventing syphilis.
Med Times Gaz 1855;2:542-3.
2. Tsen H-F, Morgenstern H, Mack T, Peters RK.
Risk factors for penile cancer: results of a population-based case-control
study in Los Angeles County (United States). Cancer Causes Control
2001;12:267-277.[Medline]
3. Maden C, Sherman KJ, Beckmann AM, et al.
History of circumcision, medical conditions, and sexual activity and risk
of penile cancer. J Natl Cancer Inst 1993;85:19-24.[Abstract]
4. Schoen EJ. The status of circumcision of newborns. N Engl J Med
1990;322:1308-1312.[Medline]
5. Weiss GN. Prophylactic neonatal surgery and infectious diseases. Pediatr Infect Dis J 1997;16:727-734.[Medline]
6. O'Farrell N, Egger M. Circumcision in men and the prevention of HIV
infection: a `meta-analysis' revisited. Int J STD AIDS
2000;11:137-142.[Medline]
7. Cameron DW, Simonsen JN, D'Costa LJ, et al.
Female to male transmission of human immunodeficiency virus type 1: risk
factors for seroconversion in men. Lancet 1989;2:403-407.[Medline]
8. Lavreys L, Rakwar JP, Thompson ML, et al. Effect of circumcision on
incidence of human immunodeficiency virus type 1 and other sexually
transmitted diseases: a prospective cohort study of trucking company
employees in Kenya. J Infect Dis 1999;180:330-336.[Medline]
9. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of
human immunodeficiency virus type 1. N Engl J Med
2000;342:921-929.[Abstract/Full Text]
10. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human
papillomaviruses. Lyons, France: International Agency for Research on
Cancer, 1995.
11. Melbye M, Frisch M. The role of human papillomaviruses
in anogenital cancers. Semin Cancer Biol 1998;8:307-313.[Medline]
12.
Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in
cervical cancer: a worldwide perspective. J Natl Cancer Inst
1995;87:796-802.[Abstract]
13. Walboomers JMM, Jacobs MV, Manos MM, et al.
Human papillomavirus is a necessary cause of invasive cervical cancer
worldwide. J Pathol 1999;189:12-19.[Medline]
14. Muñoz N, Bosch FX, de
Sanjosé S, et al. The causal link between human papillomavirus and
invasive cervical cancer: a population-based case-control study in
Colombia and Spain. Int J Cancer 1992;52:743-749.[Medline]
15. Bosch FX,
Muñoz N, de Sanjosé S, et al. Risk factors for cervical cancer in Colombia
and Spain. Int J Cancer 1992;52:750-758.[Medline]
16. Bosch FX, Muñoz N,
de Sanjosé S, et al. Human papillomavirus and cervical intraepithelial
neoplasia grade III/carcinoma in situ: a case-control study in Spain and
Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-422.[Abstract]
17.
Muñoz N, Bosch FX, de Sanjosé S, et al. Risk factors for cervical
intraepithelial neoplasia grade III/carcinoma in situ in Spain and
Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:423-431.[Abstract]
18.
Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM. Human
papillomavirus and invasive cervical cancer in Brazil. Br J Cancer
1994;69:114-119.[Medline]
19. Chichareon S, Herrero R, Muñoz N, et al.
Risk factors for cervical cancer in Thailand: a case-control study. J Natl
Cancer Inst 1998;90:50-57.[Abstract]
20. Ngelangel C, Muñoz N, Bosch FX,
et al. Causes of cervical cancer in the Philippines: a case-control study.
J Natl Cancer Inst 1998;90:43-49.[Abstract]
21. Bosch FX, Castellsagué X,
Muñoz N, et al. Male sexual behavior and human papillomavirus DNA: key
risk factors for cervical cancer in Spain. J Natl Cancer Inst
1996;88:1060-1067.[Abstract]
22. Muñoz N, Castellsagué X, Bosch FX, et al.
Difficulty in elucidating the male role in cervical cancer in Colombia, a
high-risk area for the disease. J Natl Cancer Inst
1996;88:1068-1075.[Abstract]
23. Castellsagué X, Ghaffari A, Daniel RW,
Bosch FX, Muñoz N, Shah KV. Prevalence of penile human papillomavirus DNA
in husbands of women with and without cervical neoplasia: a study in Spain
and Colombia. J Infect Dis 1997;176:353-361.[Medline]
24. Moreno V, Muñoz
N, Bosch FX, et al. Risk factors for progression of cervical
intraepithelial neoplasm grade III to invasive cervical cancer. Cancer
Epidemiol Biomarkers Prev 1995;4:459-467.[Abstract]
25. Hildesheim A,
Schiffman MH, Gravitt PE, et al. Persistence of type-specific human
papillomavirus infection among cytologically normal women. J Infect Dis
1994;169:235-240.[Medline]
26. Jacobs MV, de Roda Husman AM, van den Brule
AJC, Snijders PJF, Meijer CJLM, Walboomers JMM. Group-specific
differentiation between high- and low-risk human papillomavirus genotypes
by general primer-mediated PCR and two cocktails of oligonucleotide
probes. J Clin Microbiol 1995;33:901-905.[Abstract]
27. de Roda Husman AM,
Walboomers JM, Meijer CJ, et al. Analysis of cytomorphologically abnormal
cervical scrapes for the presence of 27 mucosotropic human papillomavirus
genotypes, using polymerase chain reaction. Int J Cancer
1994;56:802-806.[Medline]
28. Circumcision and cervical cancer. Lancet
1966;1:137-137.[Medline]
29. Urassa M, Todd J, Boerma JT, Hayes R, Isingo
R. Male circumcision and susceptibility to HIV infection among men in
Tanzania. AIDS 1997;11:73-80.
30. Parker SW, Stewart AJ, Wren MN, Gollow
MM, Straton JA. Circumcision and sexually transmissible disease. Med J
Aust 1983;2:288-290.[Medline]
31. Oriel JD. Natural history of genital
warts. Br J Vener Dis 1971;47:1-13.[Medline]
32. Wilson RA. Circumcision
and venereal disease. CMAJ 1947;56:54-56.
33. Aynaud O, Piron D, Bijaoui
G, Casanova JM. Developmental factors of urethral human papillomavirus
lesions: correlation with circumcision. BJU Int 1999;84:57-60.[Medline]
34. Van Howe RS. Circumcision and infectious diseases revisited. Pediatr
Infect Dis J 1998;17:1-6.[Medline]
35. Cook LS, Koutsky LA, Holmes KK.
Clinical presentation of genital warts among circumcised and uncircumcised
heterosexual men attending an urban STD clinic. Genitourin Med
1993;69:262-264.[Medline]
36. Cook LS, Koutsky LA, Holmes KK. Circumcision
and sexually transmitted diseases. Am J Public Health
1994;84:197-201.[Abstract]
37. Donovan B, Bassett I, Bodsworth NJ. Male
circumcision and common sexually transmissible diseases in a developed
nation setting. Genitourin Med 1994;70:317-320.[Medline]
38. Brinton LA,
Li JY, Rong SD, et al. Risk factors for penile cancer: results from a
case-control study in China. Int J Cancer 1991;47:504-509.[Medline]
39. Holly EA, Palefsky JM. Factors related to risk of penile cancer: new
evidence from a study in the Pacific Northwest. J Natl Cancer Inst
1993;85:2-4.[Medline]
40. Boon ME, Susanti I, Tasche MJA, Kok LP. Human
papillomavirus (HPV)-associated male and female genital carcinomas in a
Hindu population: the male as vector and victim. Cancer
1989;64:559-565.[Medline]
41. Kjaer SK, de Villiers EM, Dahl C, et al.
Case-control study of risk factors for cervical neoplasia in Denmark. I.
Role of the "male factor" in women with one lifetime sexual partner. Int J
Cancer 1991;48:39-44.[Medline]
42. Brinton LA, Reeves WC, Brenes MM, et
al. The male factor in the etiology of cervical cancer among sexually
monogamous women. Int J Cancer 1989;44:199-203.[Medline]
43. Hussain LA,
Lehner T. Comparative investigation of Langerhans' cells and potential
receptors for HIV in oral, genitourinary and rectal epithelia. Immunology
1995;85:475-484.[Medline]
44. Szabo R, Short RV. How does male
circumcision protect against HIV infection? BMJ 2000;320:1592-1594.[Full
Text]
Appendix
The members of the International Agency for Research on Cancer (IARC)
Multicenter Cervical Cancer Study Group are as follows: N. Muñoz, S.
Franceschi, J.S. Smith, M. Plummer, IARC, Lyons, France; F.X. Bosch, S. de
Sanjosé, X. Castellsagué, V. Moreno, Institut Català d'Oncologia,
Barcelona, Spain; L.C. González, Servicio Territorial de Sanidad y
Bienestar Social, Salamanca, Spain; M. Gili, Universidad de Sevilla,
Seville, Spain; I. Izarzugaza, Euskadi Cancer Registry, Vitoria-Gasteiz,
Spain; P. Viladiu, Registre de Càncer de Catalunya, Barcelona, Spain; C.
Navarro, Consejería de Sanidad, Murcia, Spain; A. Vergara, Servicio
Provincial de Sanidad, Zaragoza, Spain; N. Ascunce, Programa de Cáncer de
Mama, Pamplona, Spain; M. Santamaria, Hospital de Navarra, Pamplona,
Spain; C.J.L.M. Meijer, J.M.M. Walboomers, P.J. Snijders, A.J. van den
Brule, Free University Hospital, Amsterdam; K.V. Shah, Johns Hopkins
University, Baltimore; R. Herrero, Proyecto Epidemiológico Guanacaste, San
José, Costa Rica; L. Tafur, N. Aristizabal, Universidad de Valle, Cali,
Colombia; P. Alonso de Ruiz, General Hospital of Mexico, Mexico City,
Mexico; S. Chichareon, Prince of Songkla University, Hat-Yai, Thailand; C.
Ngelangel, University of the Philippines, Manila, the Philippines; and J.
Eluf-Neto, Universidade de São Paulo, São Paulo, Brazil.
This article has been cited by other articles:
Adami, H.-O., Trichopoulos, D. (2002). Cervical Cancer and the Elusive
Male Factor. N Engl J Med 346: 1160-1161 [Full Text]